
Clinical research with FDA standards for the USA
Synvia
Your gateway to the leading clinical infrastructure in Latin America
Synvia supports pharmaceutical companies in the US with clinical research in compliance with the FDA, bioequivalence, analytical services, and integrated digital solutions.

A strategic partner for the US pharmaceutical industry
Synvia combines the advantages of the Brazilian market with a global standard execution, providing a single, reliable point for faster, more efficient, and compliant clinical development.
Comprehensive solutions for all stages of drug development
Clinical Research


CRO Full Service
Central Laboratory &
Analytical Development


Digital Solutions
Our numbers
Trusted by over 200 pharmaceutical companies in Brazil and around the world
Law 14.784/2024 • Decree No. 12.651/2024 (Oct/2025)
Brazil is the fastest country in Latin America to authorize clinical studies.
With the new ethical legislation, the deadlines have been drastically shortened.
A clear, efficient flow aligned with global regulatory standards and those of the FDA.

